Bortenat is a proteasome inhibitor indicated for: • treatment of patients with multiple myeloma. • treatment of patients with mantle cell lymphoma.
IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.
For procurement cost of Bortenat (bortezomib) for Injection brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the Bortenat (bortezomib) for Injection medicine cost price in India.
The order for Bortenat (bortezomib) for Injection will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Bortezomib, sold under the brand name Bortenat among others, is an anti-cancer medication used to treat multiple myeloma and mantle cell lymphoma. This includes multiple myeloma in those who have and have not previously received treatment. It is generally used together with other medications. It is given by injection.
Bortenat (bortezomib) for Injection For subcutaneous or intravenous use.
Generic Name: bortezomib
Single-use vial contains 3.5 mg of bortezomib as lyophilized powder.
IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Bortenat (bortezomib) for Injection on prescription and Import License in Patient's Name only.
For overseas patients, Bortenat (bortezomib) for Injection can be made available. Send your enquiry to find the Atriance cost or bortezomib price in India, China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
For Bortenat (bortezomib) for Injection Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details